✦ LIBER ✦

Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies

✍ Scribed by N. J. Welton; S. R. Willis; A. E. Ades

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 230 KB
Volume: 1
Category: Article
ISSN: 1759-2879
DOI: 10.1002/jrsm.21

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer-specific survival outcomes among

Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005) : A benchmark for emerging targeted cancer therapies

✍ Arie S. Belldegrun; Tobias Klatte; Brian Shuch; Jeffrey C. LaRochelle; David C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Prognosis for G1 cell-cycle regulators:

Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer

✍ Michalides, Rob 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Cancer cells arise from an increasing genetic disarray affecting control over proliferation, self-defence, and senescence. Multiple mechanisms with a multitude of players are invoked in the genetic distortion which leads to tumour progression in different tissues. Tumour pathology is in need of a cl

2042 Long term outcome of treatment for

2042 Long term outcome of treatment for ann arbor stage I Hodgkin's disease: Prognostic factors for survival and freedom from progression

✍ Maria T. Vlachaki; Fredrick B. Hagemeister; Lillian M. Fuller; Pelayo C. Besa; M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A Comparison of Survival and Disease-Spe

A Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ David H. Garfield; Wilbur A. Franklin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

T he recent article by Varlotto et al 1 raises issues that are prob- lematic in the recent and current bronchioloalveolar (BAC) literature. The third edition of the 1999 World Health Organization (WHO) consensus classification redefined BAC as an in situ tumor with a pure BAC growth pattern and with

A comparison of survival and disease-spe

A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer : Implications for adjuvant therapy

✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to assess whether disease‐specific survival (DSS) and overall survival (OS) differed among patients who had N1 and N2 bronchioloalveolar carcinoma (BAC) compared with patients who had non‐BAC nonsmall cell lung cancer (NSCLC). ## METHODS

Reply to a Comparison of Survival and Di

Reply to a Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views